Last Updated: June 25, 2026

PRISMASOL BGK 4 Drug Patent Profile


✉ Email this page to a colleague

« Back to Dashboard


When do Prismasol Bgk 4 patents expire, and when can generic versions of Prismasol Bgk 4 launch?

Prismasol Bgk 4 is a drug marketed by Vantive Us Hlthcare and is included in one NDA.

The generic ingredient in PRISMASOL BGK 4 is calcium chloride; dextrose; lactic acid; magnesium chloride; potassium chloride; sodium bicarbonate; sodium chloride. There are two hundred and eighty-two drug master file entries for this compound. One supplier is listed for this compound. Additional details are available on the calcium chloride; dextrose; lactic acid; magnesium chloride; potassium chloride; sodium bicarbonate; sodium chloride profile page.

AI Deep Research
Ask!
Questions you can ask:
  • What is the 5 year forecast for PRISMASOL BGK 4?
  • What are the global sales for PRISMASOL BGK 4?
  • What is Average Wholesale Price for PRISMASOL BGK 4?
Summary for PRISMASOL BGK 4
US Patents:0
Applicants:1
NDAs:1
DailyMed Link:PRISMASOL BGK 4 at DailyMed
Drug patent expirations by year for PRISMASOL BGK 4

US Patents and Regulatory Information for PRISMASOL BGK 4

Glossary
Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Vantive Us Hlthcare PRISMASOL BGK 4/0 IN PLASTIC CONTAINER calcium chloride; dextrose; lactic acid; magnesium chloride; potassium chloride; sodium bicarbonate; sodium chloride INJECTABLE;INJECTION 021703-005 Oct 25, 2006 DISCN No No ⤷  Start Trial ⤷  Start Trial ⤷  Start Trial
Vantive Us Hlthcare PRISMASOL BGK 4/3.5 IN PLASTIC CONTAINER calcium chloride; dextrose; lactic acid; magnesium chloride; potassium chloride; sodium bicarbonate; sodium chloride INJECTABLE;INJECTION 021703-008 Oct 25, 2006 DISCN No No ⤷  Start Trial ⤷  Start Trial ⤷  Start Trial
Vantive Us Hlthcare PRISMASOL BGK 4/0/1.2 IN PLASTIC CONTAINER calcium chloride; dextrose; lactic acid; magnesium chloride; potassium chloride; sodium bicarbonate; sodium chloride INJECTABLE;INJECTION 021703-015 Oct 10, 2008 RX Yes Yes ⤷  Start Trial ⤷  Start Trial ⤷  Start Trial
Vantive Us Hlthcare PRISMASOL BGK 4/2.5 IN PLASTIC CONTAINER calcium chloride; dextrose; lactic acid; magnesium chloride; potassium chloride; sodium bicarbonate; sodium chloride INJECTABLE;INJECTION 021703-004 Oct 25, 2006 RX Yes Yes ⤷  Start Trial ⤷  Start Trial ⤷  Start Trial
>Applicant >Tradename >Generic Name >Dosage >NDA >Approval Date >TE >Type >RLD >RS >Patent No. >Patent Expiration >Product >Substance >Delist Req. >Exclusivity Expiration

Subscribe to access the full database, or Start Trial

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. We do not provide individual investment advice. This service is not registered with any financial regulatory agency. The information we publish is educational only and based on our opinions plus our models. By using DrugPatentWatch you acknowledge that we do not provide personalized recommendations or advice. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

 
© Copyright 2002-2026 thinkBiotech LLC
ISSN: 2162-2639
Secure SSL Encrypted
Privacy and Cookies
Terms & Conditions
Site Map
DrugPatentWatch Alternatives
LOE / Major Patent Expirations 2026 - 2027
 NCE-1 Patent Challenge Dates 2026 - 2027
Preferred Citation:

Friedman, Yali. "DrugPatentWatch" DrugPatentWatch, thinkBiotech, 2026, www.DrugPatentWatch.com.
   See Primary Research Papers Citing DrugPatentWatch

Links